Back to ENGNW
MARSHALL WACE, LLP ENGNW Position History
enGene Therapeutics Inc. • Healthcare
Quarters held
18
Latest value
$2.3M
Q1 2026
Peak value
$7.6M
First seen
Q4 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2023 | $574K |
| Q1 2024 | $5.9M |
| Q1 2024 | $7.6M |
| Q1 2024 | $509K |
| Q2 2024 | $3.2M |
| Q2 2024 | $4M |
| Q2 2024 | $159K |
| Q3 2024 | $2.4M |
| Q3 2024 | $2.1M |
| Q4 2024 | $1.2M |
| Q4 2024 | $2.4M |
| Q4 2024 | $348K |
| Q1 2025 | $1.5M |
| Q1 2025 | $5K |
| Q2 2025 | $1.3M |
| Q3 2025 | $2.3M |
| Q4 2025 | $3.1M |
| Q1 2026 | $2.3M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q1 2026 | $2.3M | 343.9K | — | — |
| Q4 2025 | $3.1M | 343.9K | — | — |
| Q3 2025 | $2.3M | 343.9K | — | — |
| Q2 2025 | $1.3M | 343.9K | — | — |
| Q1 2025 | $5K | 1.1K | — | — |
| Q1 2025 | $1.5M | 344.3K | — | — |
| Q4 2024 | $348K | 52.4K | — | — |
| Q4 2024 | $2.4M | 362.2K | — | — |
| Q4 2024 | $1.2M | 179.2K | — | — |
| Q3 2024 | $2.1M | 314.1K | — | — |
| Q3 2024 | $2.4M | 367.5K | — | — |
| Q2 2024 | $159K | 16.8K | — | — |
| Q2 2024 | $4M | 420.4K | — | — |
| Q2 2024 | $3.2M | 344.2K | — | — |
| Q1 2024 | $509K | 35.7K | — | — |
| Q1 2024 | $7.6M | 450.0K | — | — |
| Q1 2024 | $5.9M | 350.0K | — | — |
| Q4 2023 | $574K | 62.1K | — | — |